Covid Protection Wanes Months After Second Shot, Studies Show

Covid Protection Wanes Months After Second Shot, Studies Show
Alisa Odenheimer and Robert Langreth   (Bloomberg) — Immunity provided by the Covid-19 vaccine from partners Pfizer Inc. and BioNTech SE weakens significantly within months, with men having less protection than women, according to research that supports the use of booster doses. © Bloomberg A Senior Living Facility Administers A Third Covid-19 Dose To ResidentsProtective antibodies decreased continuously during the six months after the administration of the second dose of the vaccine, according to a study of about 5,000 Israeli health workers, published Wednesday in the New England Journal of Medicine.… Read the rest

‘Entirely Unsurprising’: Merck Slammed for 4,000% Markup of Taxpayer-Funded Covid Drug

‘Entirely Unsurprising’: Merck Slammed for 4,000% Markup of Taxpayer-Funded Covid Drug
“Another example of Big Pharma reaping billions from public investment into research by charging extortionate, rip-off prices for lifesaving Covid drugs.” JAKE JOHNSON October 6, 2021 The New Jersey-based pharmaceutical giant Merck is facing accusations of price gouging after it charged the U.S. over $700 per patient for a taxpayer-funded coronavirus treatment that, according to research, costs just $17.74 to produce.… Read the rest

US State With Highest Vaccination Rate Hit by Virus Surge

US State With Highest Vaccination Rate Hit by Virus Surge
By Ivan Pentchoukov October 5, 2021 Vermont, the state with the highest vaccination rate in the United States, is experiencing a CCP virus surge at levels not seen since the pandemic’s peak last winter. The number of cases in Vermont is at a record level, hospitalizations are close to the records notched last winter, and the state recorded the deadliest day and the second deadliest month of the pandemic in September.… Read the rest

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
Mayte Sánchez van Kammen, MD1; Diana Aguiar de Sousa, MD, PhD2; Sven Poli, MD, MSc3,4; et alCharlotte Cordonnier, MD, PhD5; Mirjam R. Heldner, MD, MSc6; Anita van de Munckhof, MD1; Katarzyna Krzywicka, MD, MPhil1; Thijs van Haaps, BSc7; Alfonso Ciccone, MD, PhD8; Saskia Middeldorp, MD, PhD9; Marcel M. Levi, MD, PhD10; Johanna A. Kremer Hovinga, MD11; Suzanne Silvis, MD, PhD12; Sini Hiltunen, MD, PhD13; Maryam Mansour, MD14; Antonio Arauz, MD, PhD15; Miguel A. … Read the rest